Source: PR Newswire
I Peace, Inc. (CEO: Koji Tanabe, https://ipeace.com/), a Palo Alto-based biotech startup focusing on Nobel Prize-wining technology of induced pluripotent stem cells (iPSCs) has successfully developed a novel system to mass manufacture clinical-grade iPSCs for cell therapy in a palm-size closed cassette.
As the world of stem cell research advances, more options may become available to patients with RA and other autoimmune diseases.
Source: Pain News Network
A Canadian doctor is recruiting patients for a "first of its kind" stem cell research project for osteoarthritis. The Phase II study could further advance the use of regenerative medicine in treating osteoarthritis, a joint disease for which treatment options are currently limited to pain medication, steroid injections or joint replacement surgery.
In new research from the Wake Forest Institute for Regenerative Medicine (WFIRM), scientists have shown that bioengineered uteri supported fertilization, fetal development, and live birth with normal offspring.
According to the American Society of Gene & Cell Therapy, regenerative medicine may be defined as a branch of medicine that aims to repair damaged tissue. “Repair” may involve the replacement or regeneration of human cells, tissues, or organs.
Scientists at RCSI University of Medicine and Health Sciences have developed a new biomaterial that has the potential to accelerate bone regeneration by promoting an immune response that encourages repair and lowers the risk of inflammation.
Source: Mining Journal
Amniotic materials have many applications in medicine, especially sports medicine. The beneficial properties of amniotic fluid have it poised to become a major player in the healthcare market, especially with the trend-setter, Medicare, leading the way.